Syra Health Corp (SYRA) Stock Price & Analysis

Syra Health Corp (SYRA) fell 4.42% to USD 0.67 as of July 25, 2026 at 15:04 UTC, according to Nexqual real-time market data.

SYRA last closed at USD 0.7; the session ranged USD 0.67–0.7 on volume of 10,577 shares. Market capitalization is $9.51M, with a 52-week range of USD 0.05–1.15 (OQB). Source: Nexqual, July 25, 2026 at 15:04 UTC.

Key Statistics (as of July 25, 2026 at 15:04 UTC)

PriceUSD 0.67
Change▼ 4.42% (down)
Previous CloseUSD 0.7
OpenUSD 0.7
Day RangeUSD 0.67 – 0.7
52-Week RangeUSD 0.05 – 1.15
Volume10,577 shares
Market Cap$9.51M
ExchangeOQB

Technical Analysis (SYRA)

Nexqual's technical model rates SYRA "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 15:04 UTC.

Overall SignalNEUTRAL
RSI (14)50.05 (neutral)
vs SMA50Above (USD 0.57)
MACD0.05 (positive)

Analyst Ratings (SYRA)

Wall Street analysts rate SYRA "None", per Nexqual as of July 25, 2026 at 15:04 UTC.

Consensus RatingNone

Earnings (SYRA)

Source: Nexqual, July 25, 2026 at 15:04 UTC.

Financials & Fundamentals (SYRA)

Total Revenue$7.64M
Revenue Growth (YoY)+22.40%
Gross Margin+37.55%
Operating Margin+8.40%
Profit Margin-2.40%
ROE-7.60%
Debt / Equity3.09
Current Ratio2.48
Total Cash$2.92M
Total Debt$73,086
Free Cash Flow$470,013

Source: Nexqual, July 25, 2026 at 15:04 UTC.

Financial Health Score (SYRA)

Nexqual rates Syra Health Corp's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 15:04 UTC.

GrowthCritical — Revenue -100% YoY (annual), sharp decline
ProfitabilityWeak — Pre-revenue or very early stage
Balance SheetStrong — $3M cash, no debt
Cash FlowSolid — Operating cash flow $756K
EfficiencyCritical — ROE -8%, ROA -3.9%

Ownership (SYRA)

Insider Ownership+52.43%
Institutional Ownership+0.00%
Shares Outstanding13.84M
Float6.81M
Short % of Float+4.10%

Source: Nexqual, July 25, 2026 at 15:04 UTC.

Leadership (SYRA)

Syra Health Corp is led by Gregory R. Alexander (age 56), Chief Executive Officer, per Nexqual as of July 25, 2026 at 15:04 UTC.

Chief Executive OfficerGregory R. Alexander (age 56)
CFO, COO & DirectorPriya Prasad (age 47)
IR/PR, Communications & Marketing DirectorChristine Drury
Senior Executive Director of People & OperationsJacop Lucas

Major Backers & Investors (SYRA)

Notable institutional backers of Syra Health Corp include Jane Street Group, LLC, Xtx Topco Ltd, according to Nexqual as of July 25, 2026 at 15:04 UTC.

Active Investors

InvestorStake
Jane Street Group, LLC1.32%
Xtx Topco Ltd0.2%

Index Funds (Passive)

FundStake
Vanguard Group0.3%

Source: Nexqual, July 25, 2026 at 15:04 UTC.

From Syra Health Corp's Latest SEC 10-K Filing (filed 2026-03-12)

Key Strengths & Strategy (as disclosed to the SEC)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
HKITHitek Global Inc.USD 3.56▼ 3.78%
MGIHMillennium Group International USD 1.62▼ 2.41%
CCTGCCSC Technology International HUSD 0.79▼ 1.57%
ARBBARB IOT Group LimitedUSD 4.17▼ 4.03%
OMHOhmyhome LimitedUSD 0.5▲ 39.45%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:04 UTC. This page is informational and not investment advice.